Private Equity

RPM International's 52nd straight year of dividend hikes cements its 'Dividend King' status. We look at the strategy behind this rare achievement.

Following the sale of its legacy business, the newly-rebranded Accendra Health launches on the NYSE with a laser focus on the booming home healthcare market.

As INCERGO finalizes its Visual Semiconductor merger, it's betting on GF3D™ tech to revive 3D displays. Can it succeed where 3D TVs failed?

Neovii Pharmaceuticals names Frédéric Prince its next CEO, bringing deep oncology and gene therapy experience from Roche to steer its next growth phase.

Ecovyst completes a major divestiture to slash debt and focus on its core, while Technip Energies acquires key assets to boost its energy transition goals.

Distressed debt giant Silver Point Capital acquires a controlling interest in claims against bankrupt auto parts maker First Brands, a strategic move.

The MICE giant's massive government contract to manage a 185,000-pilgrim yatra signals a strategic shift and a new model for public-private partnerships.

The revered former U.S. Senator announced his withdrawal from public life following a dementia diagnosis, ending a storied career and sparking reflection.

Vivakor blames a government shutdown for its dividend delay, but shareholders are left grappling with an unusual asset and a complex CEO-related deal.

ECN Capital urges shareholders to approve a C$1.9 billion takeover by Warburg Pincus, offering a 13% premium and a shift to private ownership.

As Aircastle prepares its Q3 2025 results, all eyes are on the leasing giant for insights into the supercharged global aviation finance sector.

Interim CFO Donna Granato's departure marks a pivotal moment for Ayr Wellness as it completes a massive debt restructuring and transitions to a new entity.

Euromax Resources raised C$1.6M, but with 84% for overhead and only 9% for its stalled gold project, is this a step forward or just staying afloat?

Privately held MMMera hires strategic firm CND-SA to scale its Guillotine® gaming IP, a move highlighting the high-stakes game of professionalizing art.

Italian luxury knitwear maker Zanieri completes a reverse merger with Everlert, Inc., gaining a US public listing to fund global expansion and brand growth.

A critical railway is down, halting iron ore shipments. Champion Iron projects calm, but the incident highlights logistical risks in a bullish market.

INVO Fertility realigns its top brass, positioning a deal-making veteran to lead an aggressive clinic acquisition strategy in a booming market.

Hyatt finalizes a $2B asset sale to Tortuga Resorts, advancing its asset-light strategy while navigating hurricane recovery in the Caribbean.

The investment firm renews its plan to repurchase up to 5% of its units, signaling a strong belief that its market price is below its intrinsic value.

Emmaus Life Sciences outsources its sickle cell drug Endari® in North America to focus on global growth, as NeoImmuneTech gains a key U.S. market foothold.